A solid pharmaceutical dosage formulation

Details for Australian Patent Application No. 2012202831 (hide)

Owner Abbott Laboratories

Inventors Liepold, Bernd; Berndl, Gunther; Rosenberg, Joerg; Reinhold, Ulrich; Alani, Laman; Ghosh, Soumojeet; Breitenbach, Jorg

Agent Spruson & Ferguson

Pub. Number AU-A-2012202831

Parent 2006216856

Filing date 15 May 2012

Wipo publication date 7 June 2012

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/426 (2006.01) - 1,3-Thiazoles

Event Publications

31 May 2012 Complete Application Filed

7 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202831

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202832-Foam generating device for fire hoses

2012202830-Method for energy-based stimulation of acupuncture meridians